- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abbvie Inc DRC (ABBVm)
Abbvie Inc DRC stock price live, this page displays BCBA ABBVm stock exchange data. View the ABBVm premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abbvie Inc DRC real time stock price chart below.
What Is the Abbvie Inc DRC Stock Price Today?
The Abbvie Inc DRC stock price today is 24,325.00.
What Is the Stock Symbol for Abbvie Inc DRC?
The stock symbol for Abbvie Inc DRC is ""ABBVm.""
What Stock Exchange Does Abbvie Inc DRC Trade On?
Abbvie Inc DRC is listed and trades on the Buenos Aires stock exchange.
Is Abbvie Inc DRC a Good Stock to Buy?
Determining whether Abbvie Inc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABBVm quote. (ISIN: ARBCOM4603M9)
What Is the Abbvie Inc DRC Stock Price Today?
The Abbvie Inc DRC stock price today is 24,325.00.
What Is the Stock Symbol for Abbvie Inc DRC?
The stock symbol for Abbvie Inc DRC is ""ABBVm.""
What Stock Exchange Does Abbvie Inc DRC Trade On?
Abbvie Inc DRC is listed and trades on the Buenos Aires stock exchange.
Is Abbvie Inc DRC a Good Stock to Buy?
Determining whether Abbvie Inc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABBVm quote. (ISIN: ARBCOM4603M9)
24,325.00
+225.00(+0.93%)
Closed·
Fair Value
An estimate of a Abbvie's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24,150.00
24,400.00
52 wk Range
18,325.00
27,925.00
ABBVm Scorecard
Full Analysis
Has raised its dividend for 12 consecutive years
ABBVm is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Abbvie's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24,150.0024,400.00
52 wk Range
18,325.0027,925.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ABBVm Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Abbvie's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Abbvie Inc DRC Company Profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Compare ABBVm to Peers and Sector
Metrics to compare | ABBVm | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABBVmPeersSector | |
|---|---|---|---|---|
P/E Ratio | 81.0x | −2.9x | −0.5x | |
PEG Ratio | −2.67 | 0.04 | 0.00 | |
Price/Book | 237.0x | 2.7x | 2.6x | |
Price / LTM Sales | 5.9x | 8.4x | 3.2x | |
Upside (Analyst Target) | - | 33.2% | 40.5% | |
Fair Value Upside | Unlock | 22.9% | 4.4% | Unlock |
Earnings
Latest Release
May 09, 2025
EPS / Forecast
0.72 / --
Revenue / Forecast
13.34B / --
People Also Watch
FAQ
What Stock Exchange Does Abbvie Trade On?
Abbvie is listed and trades on the Buenos Aires Stock Exchange stock exchange.
What Is the Stock Symbol for Abbvie?
The stock symbol for Abbvie is "ABBVm."
What Is the Abbvie Market Cap?
As of today, Abbvie market cap is 429.11T.
What Is Abbvie's Earnings Per Share (TTM)?
The Abbvie EPS (TTM) is 2.35.
From a Technical Analysis Perspective, Is ABBVm a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Abbvie Stock Split?
Abbvie has split 0 times.
How Many Employees Does Abbvie Have?
Abbvie has 55000 employees.
What is the current trading status of Abbvie (ABBVm)?
As of 25 Jul 2025, Abbvie (ABBVm) is trading at a price of 24,325.00, with a previous close of 24,325.00. The stock has fluctuated within a day range of 24,150.00 to 24,400.00, while its 52-week range spans from 18,325.00 to 27,925.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.